Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Libianto

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Critical Care Clinics|February 21, 2019
New Agents for the Treatment of Type 2 DiabetesRenata Libianto, Elif I Ekinci
Australian Journal of General Practice|February 5, 2021
Adrenal disease: An updateRenata Libianto, Jun Yang, Peter J Fuller
The Medical Journal of Australia|January 8, 2020
Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomesRenata Libianto, Timothy Me Davis, Elif I Ekinci
The Medical Journal of Australia|March 31, 2022
Plasma aldosterone to renin ratio for the detection of primary aldosteronism in patients with drug-resistant hypertensionKay W Choy, Renata Libianto, Ian Simpson, et al.
Internal Medicine Journal|January 9, 2022
Screening for primary aldosteronism in the diabetic population: a cohort studySuzanne J Tan, Renata Libianto, Jun Yang, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 9, 2023
Improving Detection Rates for Primary AldosteronismRenata Libianto, Michael Stowasser, Grant Russell, et al.
Journal of Human Hypertension|April 29, 2020
Primary aldosteronism is a public health issue: challenges and opportunitiesRenata Libianto, Peter J Fuller, Morag J Young, et al.
Family Practice|June 24, 2024
Screening for primary aldosteronism in primary care: a scoping reviewKirsten Tsan, Jun Yang, Abhir Nainani, et al.
Bone|March 17, 2019
KBG syndrome presenting with brachydactyly type ERenata Libianto, Kathy Hc Wu, Sophie Devery, et al.
Endocrine Reviews|May 26, 2026
Beyond aldosterone and renin: emerging biomarkers for diagnosing and subtyping primary aldosteronismRenata Libianto, Charlotte L Uniacke, Peter J Fuller, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Critical Care Clinics|February 21, 2019
New Agents for the Treatment of Type 2 DiabetesRenata Libianto, Elif I Ekinci
Australian Journal of General Practice|February 5, 2021
Adrenal disease: An updateRenata Libianto, Jun Yang, Peter J Fuller
The Medical Journal of Australia|January 8, 2020
Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomesRenata Libianto, Timothy Me Davis, Elif I Ekinci
The Medical Journal of Australia|March 31, 2022
Plasma aldosterone to renin ratio for the detection of primary aldosteronism in patients with drug-resistant hypertensionKay W Choy, Renata Libianto, Ian Simpson, et al.
Internal Medicine Journal|January 9, 2022
Screening for primary aldosteronism in the diabetic population: a cohort studySuzanne J Tan, Renata Libianto, Jun Yang, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 9, 2023
Improving Detection Rates for Primary AldosteronismRenata Libianto, Michael Stowasser, Grant Russell, et al.
Journal of Human Hypertension|April 29, 2020
Primary aldosteronism is a public health issue: challenges and opportunitiesRenata Libianto, Peter J Fuller, Morag J Young, et al.
Family Practice|June 24, 2024
Screening for primary aldosteronism in primary care: a scoping reviewKirsten Tsan, Jun Yang, Abhir Nainani, et al.
Bone|March 17, 2019
KBG syndrome presenting with brachydactyly type ERenata Libianto, Kathy Hc Wu, Sophie Devery, et al.
Endocrine Reviews|May 26, 2026
Beyond aldosterone and renin: emerging biomarkers for diagnosing and subtyping primary aldosteronismRenata Libianto, Charlotte L Uniacke, Peter J Fuller, et al.
Pageof 4